Status Approved
First Submitted Date
2020/07/03
Registered Date
2021/03/25
Last Updated Date
2021/03/17
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0006028 |
---|---|
Unique Protocol ID | PC20OADI0023 |
Public/Brief Title | Outcome of Modular Dual Mobility Total Hip Arthroplasty in Healthy Elderly |
Scientific Title | Modular Dual Mobility Total Hip Arthroplasty Compared with Fixed Bearing Total Hip Arthroplasty for Femoral Neck Fractures in the Healthy Elderly |
Acronym | |
MFDS Regulated Study | No |
IND/IDE Protocol | No |
Registered at Other Registry | No |
Healthcare Benefit Approval Status | Not applicable |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted approval |
---|---|
Board Approval Number | PIRB-신20200507-039 |
Approval Date | 2020-05-07 |
Institutional Review Board Name | Eunpyung St. Mary's Hospital Institutional Review Board |
Institutional Review Board Address | 405, Byulgwan, Eunpyung Saint Mary's Hospital, 1021, Tongil-ro, Eunpyeong-gu, Seoul, Republic of Korea |
Institutional Review Board Telephone | 02-2030-3715 |
Data Monitoring Committee |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | Seung-Chan Kim |
Title | Assistant professor |
Telephone | +82-2-2030-4628 |
Affiliation | The Catholic University of Korea, Eunpyeong St. Mary's Hospital |
Address | Eunpyung Saint Mary's Hospital, 1021, Tongil-ro, Eunpyeong-gu, Seoul, Republic of Korea |
Contact Person for Public Queries | |
Name | Seung-Chan Kim |
Title | Assistant professor |
Telephone | +82-2-2030-4628 |
Affiliation | The Catholic University of Korea, Eunpyeong St. Mary's Hospital |
Address | Eunpyung Saint Mary's Hospital, 1021, Tongil-ro, Eunpyeong-gu, Seoul, Republic of Korea |
Contact Person for Updating Information | |
Name | Seung-Chan Kim |
Title | Assistant professor |
Telephone | +82-2-2030-4628 |
Affiliation | The Catholic University of Korea, Eunpyeong St. Mary's Hospital |
Address | Eunpyung Saint Mary's Hospital, 1021, Tongil-ro, Eunpyeong-gu, Seoul, Republic of Korea |
4. Status
Study Site | Multi-center Number of center : 2 | |
---|---|---|
Overall Recruitment Status | Recruiting | |
Date of First Enrollment | 2021-03-02 Actual | |
Target Number of Participant | 120 | |
Primary Completion Date | ||
Study Completion Date | ||
Recruitment Status by Participating Study Site 1 | ||
Name of Study | The Catholic University of Korea, Eunpyeong St. Mary's Hospital | |
Recruitment Status | Recruiting | |
Date of First Enrollment | 2021-03-02 , | |
Recruitment Status by Participating Study Site 2 | ||
Name of Study | The Catholic University of Korea, Seoul St. Mary's Hospital | |
Recruitment Status | Recruiting | |
Date of First Enrollment | 2021-03-02 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | The Catholic University of Korea, Eunpyeong St. Mary's Hospital |
Organization Type | Medical Institute |
Project ID |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | The Catholic University of Korea, Eunpyeong St. Mary's Hospital |
Organization Type | Medical Institute |
7. Study Summary
Lay Summary | Almost all femoral neck fractures require surgery, and bipolar hemiarthroplasties(BPHA) and total hip arthroplasties(THA) are occasionaly used. THAs are preferred in that it show better recovery and lesser inguinal pains than BPHAs, but have complications of dislocations which often leads to revisional surgeries. Over 65 years old population and in turn osteoporotic femoral neck fractures are anticipated to increase exponentially, and older aged patients have higher risk of disclocations, which are recently lowered with the introduction of dual mobility constructs. However, they have concerns of increased articular surface wear due to additional mobile surface compared with fixed bearing arthroplasties. Head-to-head studies have been conducted recently, but multicentered, randomized controll trials have not been yet introduced. Patients admitted via emergency rooms or outpatient departents will be random block (4 to 6 patients in a block) assigned in to two groups: (1) Fixed bearing total hip arthroplasty, and (2) Modular dual mobility total hip arthroplasty. Outcomes will be measured up to 2 years after surgery. Additionaly, duration of anesthesia, estimated blood loss, required transfusions will be compared and also pain measurements (VAS pain scale), clinical scores (Harris hip score, WOMAC score), patient satisfactory measurements, ambulation status (Koval stage) will be evaluated. Above mentioned radiological parameters and clinical evaluations are routinely checked assessment tools. Also operative techniques used in the study is internationally and traditionally used treatment of choice. Therefore unexpected or additionally dangerous complications are not to be worrisome in this study. |
---|
8. Study Design
Study Type | Interventional Study |
---|---|
Study Purpose | Treatment |
Phase | Not applicable |
Intervention Model | Parallel |
Blinding/Masking | Open |
Allocation | RCT |
Intervention Type | /Procedure/Surgery |
Intervention Description | Patients admitted via emergency rooms or outpatient departents will be random block (4 to 6 patients in a block) assigned in to two groups: (1) Fixed bearing total hip arthroplasty, and (2) Modular dual mobility total hip arthroplasty. Outcomes will be measured up to 2 years after surgery. |
Number of Arms | 2 |
Arm 1 |
Arm Label Modular Dual Mobility Total Hip Arthroplasty |
Target Number of Participant 60 |
|
Arm Type Experimental |
|
Arm Description Dual mobility total hip arthroplasties are performed by inserting dual mobility implants: liner & cup. The liner and cup are coupled inside the operative field before insertion to form the implant hip joint. |
|
Arm 2 |
Arm Label Fixed Bearing Total hip Arthroplasty |
Target Number of Participant 60 |
|
Arm Type Experimental |
|
Arm Description Traditionally applied fixed bearing total hip arthroplasty technique uses currently widely used fixed bearing liner and cups to form the implant hip joint. |
9. Subject Eligibility
Condition(s)/Problem(s) |
(M00-M99)Diseases of the musculoskeletal system and connective tissue
'Femoral Neck Fractures' in healthy elderly |
---|---|
Rare Disease | No |
Inclusion Criteria |
Gender Both |
Age 50Year~85Year |
|
Description Patients with femoral neck fractures from age of 50 to 85 years who require total hip arthroplasty Indepent ambulation before the fracture Agrees and willing to participate in ambulation rehabilitation |
|
Exclusion Criteria |
High fall risk patients (Parkinson's disesae, dementia, etc.) Previous hip surgery History of local infections, sepsis or severe infections to lower extremity Neurogenic sequelae due to previous cerebrovascular accident Unable to independently ambulate before the onset of fracture 85 years or older Patients who are unable to attend follow up schedules |
Healthy Volunteers | Yes |
10. Outcome Measure(s)
Type of Primary Outcome | /Safety/Efficacy | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | Dislocation rate |
|
Timepoint | 6 weeks, 6 months, 1 year, and 2 years after the surgery |
|
Primary Outcome(s) 2 | ||
Outcome | Revision surgery rate |
|
Timepoint | 6 weeks, 6 months, 1 year, and 2 years after the surgery |
|
Secondary Outcome(s) 1 | ||
Outcome | Complication rates (PTE/DVT, pressure sore, surgical site infection, hematome) |
|
Timepoint | 6 weeks, 6 months, 1 year, and 2 years after the surgery |
|
Secondary Outcome(s) 2 | ||
Outcome | Radiological outcomes |
|
Timepoint | 6 weeks, 6 months, 1 year, and 2 years after the surgery |
|
Secondary Outcome(s) 3 | ||
Outcome | Readmission rate (30days/90days) |
|
Timepoint | 6 weeks, 6 months, 1 year, and 2 years after the surgery |
|
Secondary Outcome(s) 4 | ||
Outcome | Mortality rate |
|
Timepoint | 6 weeks, 6 months, 1 year, and 2 years after the surgery |
|
Secondary Outcome(s) 5 | ||
Outcome | Time of anesthesia |
|
Timepoint | 6 weeks, 6 months, 1 year, and 2 years after the surgery |
|
Secondary Outcome(s) 6 | ||
Outcome | Estimated blood loss |
|
Timepoint | 6 weeks, 6 months, 1 year, and 2 years after the surgery |
|
Secondary Outcome(s) 7 | ||
Outcome | Transfusion requirements |
|
Timepoint | 6 weeks, 6 months, 1 year, and 2 years after the surgery |
|
Secondary Outcome(s) 8 | ||
Outcome | Clinical scores: VAS pain scale, Harris hip score, WOMAC score, EQ-5D index |
|
Timepoint | 6 weeks, 6 months, 1 year, and 2 years after the surgery |
|
Secondary Outcome(s) 9 | ||
Outcome | Ambulation status (Koval stage) |
|
Timepoint | 6 weeks, 6 months, 1 year, and 2 years after the surgery |
11. Study Results and Publication
Result Registered | No |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | No |
---|
TOP
BOTTOM
화면 최하단으로 이동